Results 231 to 240 of about 114,609 (356)

Recurrence Risk in Pediatric Non‐Infectious Uveitis during Adalimumab Tapering: An International Multicenter Retrospective Study

open access: yesArthritis &Rheumatology, Accepted Article.
Objectives This study aims to assess the risk of non‐infectious uveitis (NIU) relapse in pediatric patients undergoing Adalimumab (ADA) tapering, evaluating potential predictors of such risk Methods We conducted a multicenter retrospective cohort study involving pediatric NIU patients who underwent ADA tapering due to inactive uveitis. Cox proportional
Achille Marino   +31 more
wiley   +1 more source

Cancer and Placebos [PDF]

open access: yesCA: A Cancer Journal for Clinicians, 1981
openaire   +2 more sources

Placebo and placebo effects in medicine [PDF]

open access: yesJournal of the Royal Society of Medicine, 2000
Michael Emmans Dean, Joseph S Conway
openaire   +2 more sources

First‐in‐human safety, tolerability, pharmacokinetics and pilot food‐effect study of the candidate antimalarial compound MMV367

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim To evaluate the safety, tolerability and pharmacokinetics in healthy participants of orally administered MMV367 (GSK3772701), a novel antimalarial interfering with Plasmodium falciparum acyl coenzyme A synthetase 10/11 function. Methods This first‐in‐human study enrolled 47 healthy male and female participants.
Andrea Kuemmerle   +13 more
wiley   +1 more source

A Placebo-Controlled Double-Blind Crossover Investigation of the Side Effects Attributed to Oral Contraceptives

open access: bronze, 1971
Joseph W. Goldzieher   +4 more
openalex   +1 more source

Evaluation of sixteen antimotion sickness drugs under controlled laboratory conditions [PDF]

open access: yes
Evaluation of antimotion sickness drugs under controlled laboratory ...
Graybiel, A., Wood, C. D.
core   +1 more source

Home - About - Disclaimer - Privacy